Investigating how alcohol use affects lung health after TB treatment in people with HIV
The Role of Alcohol Use in Lung Disease After Treatment for Active TB Disease Among Persons Living with HIV
This study is looking at how drinking too much alcohol affects lung health in people with HIV who have finished treatment for tuberculosis, and it aims to help improve their health by understanding these risks better.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10904862 on NIH RePORTER |
What this research studies
This research examines the impact of hazardous alcohol consumption on lung health in individuals living with HIV who have completed treatment for tuberculosis (TB). The study will involve 200 participants in Mbarara, Uganda, where researchers will assess various lung health outcomes, including exercise capacity, lung function, and lung anatomy through CT scans. By identifying the relationship between alcohol use and post-TB lung disease, the research aims to highlight modifiable risk factors that could improve health outcomes for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who have recently completed treatment for pulmonary tuberculosis and engage in hazardous drinking.
Not a fit: Patients who do not have HIV or have not undergone treatment for tuberculosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for lung health in individuals living with HIV who have undergone TB treatment.
How similar studies have performed: Previous research has indicated that alcohol use can negatively impact lung health, suggesting that this study's approach is both relevant and necessary.
Where this research is happening
Boston, United States
- Boston Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: So-Armah, Kaku — Boston Medical Center
- Study coordinator: So-Armah, Kaku
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.